Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,326,057 shares
Latest Disclosed Value $ 74,730,645
Dimensional Fund Advisors Lp reports 21.33% increase in ownership of HAE / Haemonetics Corporation

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 1,326,057 shares of Haemonetics Corporation (US:HAE) valued at $74,736,573 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,092,938 shares of Haemonetics Corporation. This represents a change in shares of 21.33% during the quarter. The current value of the position is $94,521,343 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,326,057 233,119 21.33 74,731 -14.69 0.0155
2026-02-12 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,092,938 -6,581 -0.60 87,603 63.48 0.0184
2025-11-12 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,099,519 26,763 2.49 53,587 -33.05 0.0115
2025-08-12 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,072,756 9,054 0.85 80,036 18.41 0.0185
2025-05-13 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,063,702 71,473 7.20 67,595 -12.75 0.0168
2025-02-13 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 992,229 10,990 1.12 77,470 -1.78 0.0186
2024-11-07 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 981,239 2,504 0.26 78,870 -2.60 0.0191
2024-08-09 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 978,735 57,665 6.26 80,972 3.00 0.0211
2024-05-10 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 921,070 94,339 11.41 78,613 11.20 0.0213
2024-02-07 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 826,731 59,670 7.78 70,697 2.88 0.0206
2023-11-09 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 767,061 64,402 9.17 68,717 14.87 0.0225
2023-08-09 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 702,659 1,414 0.20 59,824 3.10 0.0191
2023-05-12 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 701,245 -34,984 -4.75 58,023 101,694.74 0.0195
2023-02-09 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 736,229 18,078 2.52 58 -99.89 0.0171
2022-11-10 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 718,151 34,019 4.97 53,164 19.23 0.0204
2022-08-12 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 684,132 61,035 9.80 44,591 13.21 0.0160
2022-05-13 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 623,097 69,141 12.48 39,389 34.05 0.0121
2022-02-09 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 553,956 111,878 25.31 29,383 -5.84 0.0089
2021-11-12 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 442,078 -71,171 -13.87 31,206 -8.76 0.0101
2021-08-12 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 513,249 9,144 1.81 34,203 -38.88 0.0108
2021-05-14 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 504,105 20,002 4.13 55,964 -2.65 0.0185
2021-03-08 2020-12-31 13F/A-2 HAEMONETICS COM 405024100 484,103 17,279 3.70 57,488 41.15 0.0208
2021-02-11 2020-12-31 13F HAEMONETICS COM 405024100 484,103 17,279 57,488 20,761.6099
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 466,824 45,546 10.81 40,729 7.96 0.0173
2020-08-13 2020-06-30 13F HAEMONETICS COM 405024100 421,278 -692 -0.16 37,726 -10.30 0.0166
2020-05-14 2020-03-31 13F HAEMONETICS COM 405024100 421,970 -8,773 -2.04 42,057 -15.02 0.0219
2020-02-14 2019-12-31 13F HAEMONETICS COM 405024100 430,743 -46,626 -9.77 49,491 -17.81 0.0180
2019-11-12 2019-09-30 13F HAEMONETICS COM 405024100 477,369 -88,289 -15.61 60,212 -11.54 0.0234
2019-08-13 2019-06-30 13F HAEMONETICS COM 405024100 565,658 -206,968 -26.79 68,070 0.71 0.0264
2019-08-12 2019-03-31 13F/A-2 HAEMONETICS COM 405024100 772,626 -245,433 -24.11 67,587 -33.64 0.0269
2019-05-10 2019-03-31 13F HAEMONETICS COM 405024100 772,626 -245,433 67,587
2019-02-26 2018-12-31 13F/A-1 HAEMONETICS COM 405024100 1,018,059 -278,129 -21.46 101,850 -31.42 0.0461
2019-02-13 2018-12-31 13F HAEMONETICS COM 405024100 1,018,059 -278,129 101,850
2018-11-13 2018-09-30 13F HAEMONETICS COM 405024100 1,296,188 -144,412 -10.02 148,514 14.96 0.0565
2018-08-10 2018-06-30 13F HAEMONETICS COM 405024100 1,440,600 -111,369 -7.18 129,193 13.79 0.0515
2018-05-11 2018-03-31 13F HAEMONETICS COM 405024100 1,551,969 -49,284 -3.08 113,541 22.08 0.0473
2018-02-12 2017-12-31 13F HAEMONETICS COM 405024100 1,601,253 -141,028 -8.09 93,002 18.97 0.0386
2017-11-13 2017-09-30 13F HAEMONETICS COM 405024100 1,742,281 2,547 0.15 78,173 13.79 0.0342
2017-08-11 2017-06-30 13F HAEMONETICS COM 405024100 1,739,734 40,381 2.38 68,702 -0.35 0.0317
2017-05-12 2017-03-31 13F HAEMONETICS COM 405024100 1,699,353 17,963 1.07 68,943 2.00 0.0330
2017-02-09 2016-12-31 13F HAEMONETICS COM 405024100 1,681,390 -85,970 -4.86 67,592 5.62 0.0338
2016-11-10 2016-09-30 13F HAEMONETICS COM 405024100 1,767,360 -37,562 -2.08 63,995 22.31 0.0346
2016-08-09 2016-06-30 13F HAEMONETICS COM 405024100 1,804,922 228,856 14.52 52,324 -5.09 0.0301
2016-05-13 2016-03-31 13F HAEMONETICS COM 405024100 1,576,066 126,716 8.74 55,130 17.98 0.0330
2016-02-10 2015-12-31 13F HAEMONETICS COM 405024100 1,449,350 52,491 3.76 46,728 3.50 0.0291
2015-11-13 2015-09-30 13F HAEMONETICS COM 405024100 1,396,859 109,120 8.47 45,149 -15.23 0.0296
2015-08-14 2015-06-30 13F HAEMONETICS COM 405024100 1,287,739 137,260 11.93 53,261 3.06 0.0326
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 1,150,479 212,304 22.63 51,679 47.20 0.0326
2015-02-06 2014-12-31 13F HAEMONETICS COM 405024100 938,175 63,240 7.23 35,109 14.91 0.0231
2014-11-13 2014-09-30 13F HAEMONETICS COM 405024100 874,935 113,239 14.87 30,553 13.69 0.0216
2014-08-08 2014-06-30 13F HAEMONETICS COM 405024100 761,696 919 0.12 26,873 8.39 0.0187
2014-05-14 2014-03-31 13F HAEMONETICS COM 405024100 760,777 10,092 1.34 24,793 -21.61 0.0185
2014-02-12 2013-12-31 13F HAEMONETICS COM 405024100 750,685 7,379 0.99 31,627 6.69 0.0246
2013-11-13 2013-09-30 13F HAEMONETICS COM 405024100 743,306 24,385 3.39 29,643 -0.29 0.0257
2013-08-15 2013-06-30 13F HAEMONETICS COM 405024100 718,921 718,921 29,728 0.0280
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.